A detailed history of Van Hulzen Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 151,593 shares of JNJ stock, worth $21.9 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
151,593
Previous 173,481 12.62%
Holding current value
$21.9 Million
Previous $25.4 Million 3.11%
% of portfolio
1.78%
Previous 1.7%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $3.18 Million - $3.66 Million
-21,888 Reduced 12.62%
151,593 $24.6 Million
Q2 2024

Aug 07, 2024

BUY
$144.38 - $157.78 $243,424 - $266,017
1,686 Added 0.98%
173,481 $25.4 Million
Q1 2024

May 06, 2024

SELL
$155.22 - $162.74 $235,158 - $246,551
-1,515 Reduced 0.87%
171,795 $27.2 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $218,108 - $238,002
-1,498 Reduced 0.86%
173,310 $27.2 Million
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $1.3 Million - $1.45 Million
8,337 Added 5.01%
174,808 $27.2 Million
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $729,766 - $785,368
4,728 Added 2.92%
166,471 $27.6 Million
Q1 2023

Apr 28, 2023

BUY
$151.05 - $180.26 $5.9 Million - $7.04 Million
39,032 Added 31.81%
161,743 $25.1 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $928,358 - $1.04 Million
5,795 Added 4.96%
122,711 $21.7 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $5.8 Million - $6.46 Million
-35,973 Reduced 23.53%
116,916 $19.1 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $21 Million - $23.2 Million
124,768 Added 443.68%
152,889 $27.1 Million
Q1 2022

May 20, 2022

SELL
$158.14 - $179.59 $69,739 - $79,199
-441 Reduced 1.54%
28,121 $4.98 Million
Q4 2021

Feb 04, 2022

SELL
$155.93 - $173.01 $7.7 Million - $8.55 Million
-49,392 Reduced 63.36%
28,562 $4.89 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $783,921 - $871,147
4,854 Added 6.64%
77,954 $12.6 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $339,213 - $363,865
2,127 Added 3.0%
73,100 $12 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $8.77 Million - $9.76 Million
-57,274 Reduced 44.66%
70,973 $11.7 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $1.33 Million - $1.52 Million
-9,666 Reduced 7.01%
128,247 $20.2 Million
Q3 2020

Nov 03, 2020

SELL
$140.38 - $153.83 $2.63 Million - $2.89 Million
-18,758 Reduced 11.97%
137,913 $20.5 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $728,549 - $879,564
5,656 Added 3.75%
156,671 $22 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $5.55 Million - $7.7 Million
49,978 Added 49.47%
151,015 $19.8 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $848,895 - $974,997
-6,658 Reduced 6.18%
101,037 $14.7 Million
Q3 2019

Oct 30, 2019

BUY
$126.95 - $142.14 $522,272 - $584,763
4,114 Added 3.97%
107,695 $13.9 Million
Q2 2019

Aug 08, 2019

BUY
$131.15 - $144.24 $897,852 - $987,467
6,846 Added 7.08%
103,581 $14.4 Million
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $858,541 - $954,625
6,829 Added 7.6%
96,735 $13.5 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $190,647 - $229,447
1,552 Added 1.76%
89,906 $11.6 Million
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $578,599 - $679,965
4,759 Added 5.69%
88,354 $12.2 Million
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $4.61 Million - $5.09 Million
38,651 Added 86.0%
83,595 $10.1 Million
Q1 2018

May 08, 2018

BUY
$125.1 - $148.14 $1.55 Million - $1.83 Million
12,373 Added 37.99%
44,944 $5.76 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $2.49 Million - $2.72 Million
18,969 Added 139.46%
32,571 $4.55 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $1.13 Million - $1.19 Million
8,762 Added 181.03%
13,602 $1.77 Million
Q2 2017

Aug 14, 2017

BUY
N/A
4,840
4,840 $640,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Van Hulzen Asset Management, LLC Portfolio

Follow Van Hulzen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.